Virginia Administrative Code (Last Updated: January 10, 2017) |
Title 12. Health |
Agency 5. Department of Health |
Chapter 90. Regulations for Disease Reporting and Control |
Section 230. Definitions
-
Part XII. Human Immunodeficiency Virus (HIV) Testing of Gamete Donors
The following words and terms, when used in this part, shall have the following meanings unless the context clearly indicates otherwise:
"Artificial insemination" means instrumental placement of semen into the vagina, cervical canal, or uterus of a recipient.
"Donor" means an individual who is unrelated by marriage to the recipient and who contributes sperm or ova used in the following procedures: treatment of infertility by artificial insemination; in vitro fertilization; gamete intrafallopian tube transfer; zygote intrafallopian tube transfer or any other gamete, zygote, or embryo transfer; or other intervening medical technology using sperm or ova.
"Embryo" means the product of a fertilized ovum prior to the eighth week of development inside a uterus.
"Gamete" means either sperm or ova.
"Gamete intrafallopian tube transfer" means placement of harvested ova and sperm into the fallopian tube or tubes of a recipient.
"HIV-1" means the retrovirus causing the human immunodeficiency virus infection, type 1.
"HIV-2" means the retrovirus causing the human immunodeficiency virus infection, type 2.
"In vitro fertilization" means placement of a zygote or embryo that has been fertilized outside the body into the uterus of a recipient.
"Zygote" means a fertilized ovum prior to cell cleavage.
"Zygote intrafallopian tube transfer" means placement of a zygote or zygotes into the fallopian tube or tubes of a recipient.
Historical Notes
Derived from Volume 14, Issue 26, eff. October 14, 1998.
Statutory Authority
§§ 32.1-12, 32.1-45.3 and 54.1-2971.1 of the Code of Virginia.